Offer, John L.; Voorheis, H. Paul; Metcalfe, James C., Journal of the Chemical Society. Perkin transactions I, 1992, # 8, p. 953 - 960
作者:Offer, John L.、Voorheis, H. Paul、Metcalfe, James C.、Smith, Gerry A.
DOI:——
日期:——
Synthesis of [3H]-labelled and unlabelled 2-deoxy-2-fluoro-myo-inositol and 1-deoxy-1-fluoro-scyllo-inositol for use in studies of the phosphoinositide cycle
作者:Gordon Lowe、Fiona McPhee
DOI:10.1039/p19910001249
日期:——
2-Deoxy-2-fluoro-myo-inositol and 1-deoxy-1-fluoro-scyllo-inositol have been synthesized in their unlabelled and tritiated forms in order to study their potential as inhibitors of the phosphoinositide cycle.
Radiosynthesis and in vivo tumor uptake of 2-deoxy-2-[18F]fluoro-myo-inositol
作者:Laurence Carroll、Meg Perumal、Neil Vasdev、Edward Robins、Eric O. Aboagye
DOI:10.1016/j.bmcl.2012.08.022
日期:2012.10
Inositols play an important role in membrane lipid metabolism and mitogenic signaling of most cancer cells. There is paucity of data on the distribution of radiolabelled inositols. Based on work previously carried out on 1-deoxy-1-[F-18]fluoro-scyllo-inositol ([F-18]2), we began a program of work to label myo-inositol (2-deoxy-2-[F-18]fluoro-myo-inositol, [F-18]1), the most abundant inositol in cells. Fluorination of a triflate precursor 4 afforded the desired [F-18]1 following deprotection with a radiochemical yield of 8% n.d.c. [F-18]1 showed higher uptake in vivo in a human breast cancer xenograft model, MDA-MB-231, compared to [F-18]2. Thus, we have developed a new inositol radiotracer that could have utility for studying inositol uptake in tumors. (C) 2012 Elsevier Ltd. All rights reserved.
Synthesis of 2-deoxy-2-fluorinated inositol-1-0-dodecylphosphonates as inhibitors of glycosyl phosphatidylinositol phospholipase C
作者:Hai-Xiao Zhai、Ping-Sheng Lei、James C. Morris、Kojo Mensa-Wilmot、T.Y. Shen
DOI:10.1016/0040-4039(95)01579-5
日期:1995.10
Three 2-deoxy-2-fluorinated inositols and their 1-0-dodecylphosphonate derivatives have been synthesized as non-cleavable inhibitors of glycosylphosphatidylinositolphospholipaseC. Their structure-activity relationship is discussed.